1. Home
  2. KEQU vs BWAY Comparison

KEQU vs BWAY Comparison

Compare KEQU & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$39.07

Market Cap

124.6M

Sector

Industrials

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$16.98

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
BWAY
Founded
1906
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.6M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KEQU
BWAY
Price
$39.07
$16.98
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
9.3K
59.5K
Earning Date
12-10-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
3.94
0.13
Revenue
$285,515,000.00
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
N/A
$22.24
P/E Ratio
$9.59
$52.44
Revenue Growth
43.02
27.08
52 Week Low
$30.33
$7.84
52 Week High
$71.33
$18.18

Technical Indicators

Market Signals
Indicator
KEQU
BWAY
Relative Strength Index (RSI) 47.32 52.00
Support Level $37.50 $16.75
Resistance Level $41.04 $18.18
Average True Range (ATR) 1.44 0.74
MACD 0.22 0.01
Stochastic Oscillator 51.45 55.86

Price Performance

Historical Comparison
KEQU
BWAY

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: